{
    "hands_on_practices": [
        {
            "introduction": "South-South Cooperation often presents a classic strategic dilemma: all countries may benefit from collaborating, but any single country might be tempted to act in its own short-term interest. This exercise uses game theory to model such a situation, where two countries must decide whether to engage in joint procurement ($J$) or go it alone ($S$). By analyzing the payoff matrix, you will explore why cooperation can be unstable and how triangular cooperation, in the form of a targeted incentive, can fundamentally change the strategic landscape to make collaboration the most rational choice for everyone .",
            "id": "4997284",
            "problem": "Two low- and middle-income countries (LMICs), Country $A$ and Country $B$, are deciding whether to engage in joint pooled procurement of essential medicines ($J$) or to continue solo procurement ($S$). Payoffs represent each country's net health system surplus (in millions of United States dollars) net of transaction costs. The strategic interaction is represented by the following payoff matrix, where the first entry in each ordered pair is Country $A$'s payoff and the second is Country $B$'s payoff:\n$$\n\\begin{array}{c|cc}\n & J & S \\\\\n\\hline\nJ & (8,\\,8) & (1,\\,5) \\\\\nS & (5,\\,1) & (4,\\,4)\n\\end{array}\n$$\nAssume both countries are rational and aim to maximize their own payoff. Use the core game-theoretic definitions that a strategy is strictly dominant if it yields a strictly higher payoff than every other strategy regardless of the opponent's choice, and weakly dominant if it yields a payoff at least as high as every other strategy for every opponent's choice and strictly higher for at least one opponent's choice.\n\n1) Determine whether either country has a dominant strategy in the baseline game (no external support).\n\n2) Now introduce triangular cooperation: a third partner (for example, a high-income donor) offers a per-country transfer of $t$ (in millions of United States dollars) to any country that chooses $J$, regardless of the other country's action. The transfer is added to the recipient country's payoff exactly when it chooses $J$; no transfer is paid to a country that chooses $S$. Determine the minimum value of $t$ that makes $J$ a weakly dominant strategy for both Country $A$ and Country $B$.\n\nExpress the final amount in millions of United States dollars. If rounding is required, round your answer to four significant figures. No rounding is needed if the result is exact.",
            "solution": "The problem presented is a well-defined application of game theory to a scenario in global health economics. It is scientifically grounded, self-contained, objective, and internally consistent. All data, definitions, and conditions necessary for a solution are provided. Therefore, the problem is valid and a rigorous solution can be formulated.\n\nThe problem is divided into two parts. The first part analyzes the baseline game, and the second part introduces a modification with a transfer payment and asks for the minimum value of this transfer to change the strategic nature of the game.\n\n**Part 1: Analysis of the Baseline Game**\n\nThe strategic interaction between Country $A$ and Country $B$ is represented by the following payoff matrix:\n$$\n\\begin{array}{c|cc}\n & \\text{Country B: } J & \\text{Country B: } S \\\\\n\\hline\n\\text{Country A: } J & (8,\\,8) & (1,\\,5) \\\\\n\\text{Country A: } S & (5,\\,1) & (4,\\,4)\n\\end{array}\n$$\nThe entries $(p_A, p_B)$ represent the payoffs for Country $A$ and Country $B$, respectively. We must determine if either country has a dominant strategy. A strategy is dominant if it is the best choice for a player, no matter what strategy the other player chooses.\n\nLet's analyze the choices for Country $A$:\n- If Country $B$ chooses to engage in joint procurement ($J$), Country $A$'s payoff is $8$ for choosing $J$ and $5$ for choosing $S$. Since $8 > 5$, Country $A$'s best response is $J$.\n- If Country $B$ chooses solo procurement ($S$), Country $A$'s payoff is $1$ for choosing $J$ and $4$ for choosing $S$. Since $1 < 4$, Country $A$'s best response is $S$.\n\nSince Country $A$'s optimal strategy depends on the action taken by Country $B$, Country $A$ does not have a dominant strategy (neither strictly nor weakly).\n\nNow, let's analyze the choices for Country $B$:\n- If Country $A$ chooses to engage in joint procurement ($J$), Country $B$'s payoff is $8$ for choosing $J$ and $5$ for choosing $S$. Since $8 > 5$, Country $B$'s best response is $J$.\n- If Country $A$ chooses solo procurement ($S$), Country $B$'s payoff is $1$ for choosing $J$ and $4$ for choosing $S$. Since $1 < 4$, Country $B$'s best response is $S$.\n\nSimilar to Country $A$, Country $B$'s optimal strategy depends on the action taken by Country $A$. Therefore, Country $B$ does not have a dominant strategy.\n\nIn conclusion for the first part, in the baseline game, neither country has a dominant strategy. This type of game is known as an Assurance Game or a Stag Hunt, where mutual cooperation yields the highest payoff but is risky if one player cannot trust the other to cooperate.\n\n**Part 2: Introduction of Triangular Cooperation**\n\nA third partner introduces a transfer payment $t$ to any country that chooses strategy $J$. This transfer is added to the country's payoff. The new payoff matrix becomes:\n- If both choose $J$, both receive the transfer: $(8+t, 8+t)$.\n- If $A$ chooses $J$ and $B$ chooses $S$, only $A$ receives the transfer: $(1+t, 5)$.\n- If $A$ chooses $S$ and $B$ chooses $J$, only $B$ receives the transfer: $(5, 1+t)$.\n- If both choose $S$, neither receives the transfer: $(4, 4)$.\n\nThe modified payoff matrix is:\n$$\n\\begin{array}{c|cc}\n & \\text{Country B: } J & \\text{Country B: } S \\\\\n\\hline\n\\text{Country A: } J & (8+t,\\,8+t) & (1+t,\\,5) \\\\\n\\text{Country A: } S & (5,\\,1+t) & (4,\\,4)\n\\end{array}\n$$\nWe need to find the minimum value of $t$ that makes $J$ a weakly dominant strategy for both countries.\n\nLet's establish the condition for $J$ to be a weakly dominant strategy for Country $A$. According to the definition, the payoff from choosing $J$ must be at least as high as the payoff from choosing $S$ for every possible strategy of Country $B$, and strictly higher for at least one of Country $B$'s strategies.\n\nCondition 1: If Country $B$ chooses $J$, Country $A$'s payoff from $J$ must be greater than or equal to its payoff from $S$.\n$$ \\text{Payoff}_A(J, J) \\ge \\text{Payoff}_A(S, J) $$\n$$ 8+t \\ge 5 $$\n$$ t \\ge -3 $$\n\nCondition 2: If Country $B$ chooses $S$, Country $A$'s payoff from $J$ must be greater than or equal to its payoff from $S$.\n$$ \\text{Payoff}_A(J, S) \\ge \\text{Payoff}_A(S, S) $$\n$$ 1+t \\ge 4 $$\n$$ t \\ge 3 $$\n\nFor $J$ to be a weakly dominant strategy for Country $A$, both of these conditions must be met. The intersection of the conditions $t \\ge -3$ and $t \\ge 3$ is $t \\ge 3$.\n\nAdditionally, for weak dominance, at least one of these inequalities must be strict.\nLet's test the minimum value $t=3$:\n- For Condition 1: $8+3 = 11$, and $11 \\ge 5$. This is a strict inequality ($11 > 5$).\n- For Condition 2: $1+3 = 4$, and $4 \\ge 4$. This is non-strict (an equality).\n\nSince the payoff from $J$ is strictly greater for at least one of Country $B$'s actions (namely, when $B$ chooses $J$) and not less for the other, the definition of a weakly dominant strategy is satisfied for Country $A$ when $t=3$. Any value of $t > 3$ would make both inequalities strict, making $J$ a strictly dominant strategy. Thus, the minimum value of $t$ for $J$ to be weakly dominant for Country $A$ is $t=3$.\n\nDue to the symmetry of the original game and the symmetric application of the transfer $t$, the analysis for Country $B$ is identical. For $J$ to be a weakly dominant strategy for Country $B$, it must also be that $t \\ge 3$.\n\nTherefore, the minimum value of $t$ that makes $J$ a weakly dominant strategy for both Country $A$ and Country $B$ is $3$. The units of payoffs and $t$ are in millions of United States dollars.",
            "answer": "$$\\boxed{3}$$"
        },
        {
            "introduction": "Once a cooperative health program is implemented, how can we confidently determine its impact? This question is central to evidence-based global health, and the Difference-in-Differences (DiD) method is a cornerstone of modern program evaluation. This practice challenges you to move beyond simply plugging numbers into a formula by deriving the DiD estimator from its foundational \"parallel trends\" assumption. Understanding this derivation provides a deep, intuitive grasp of how evaluators can isolate the causal effect of an intervention, like the hospital infection-prevention bundle described in the problem, from other background trends .",
            "id": "4997368",
            "problem": "A network of hospitals in two low- and middle-income countries forms a South-South Cooperation (SSC) partnership, supported by a third technical partner in a triangular cooperation arrangement (for example, facilitation by the World Health Organization (WHO)). The partnership implements a standardized infection-prevention bundle in a subset of hospitals while matched hospitals in similar urban areas do not implement it during the study period. The main outcome is the hospital-acquired infection (HAI) rate per $1{,}000$ patient-days. Let $g \\in \\{T, C\\}$ index groups, where $T$ denotes hospitals that implement the SSC intervention (treated) and $C$ denotes matched hospitals that do not (control). Let $t \\in \\{\\text{pre}, \\text{post}\\}$ index time, where $\\text{pre}$ is the period before implementation and $\\text{post}$ is the period after implementation. Denote the sample mean HAI rate for group $g$ at time $t$ by $\\bar{Y}_{g,t}$.\n\nUse the potential outcomes framework with $Y_{g,t}(1)$ representing the HAI rate the group $g$ would exhibit at time $t$ if treated and $Y_{g,t}(0)$ representing the HAI rate the group would exhibit at time $t$ if untreated. Under standard Difference-in-Differences (DiD) identification conditions, including the parallel trends assumption (that untreated trends would have been the same in $T$ and $C$), the Stable Unit Treatment Value Assumption (SUTVA) and composition stability (no systematic changes in patient mix that differentially affect trends across $T$ versus $C$), derive from first principles the sample estimator for the average effect of treatment on the treated hospitals in the $\\text{post}$ period. Then, select the option that correctly gives the estimator as a function of the observed sample means.\n\nWhich of the following expressions correctly estimates the DiD effect under the parallel trends assumption in this SSC and triangular cooperation context?\n\nA. $(\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{T,\\text{pre}}) - (\\bar{Y}_{C,\\text{post}} - \\bar{Y}_{C,\\text{pre}})$\n\nB. $\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{C,\\text{post}}$\n\nC. $(\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{T,\\text{pre}}) + (\\bar{Y}_{C,\\text{post}} - \\bar{Y}_{C,\\text{pre}})$\n\nD. $(\\bar{Y}_{C,\\text{post}} - \\bar{Y}_{C,\\text{pre}}) - (\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{T,\\text{pre}})$\n\nE. $\\dfrac{\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{C,\\text{post}}}{\\bar{Y}_{C,\\text{pre}}} - \\dfrac{\\bar{Y}_{T,\\text{pre}} - \\bar{Y}_{C,\\text{pre}}}{\\bar{Y}_{C,\\text{pre}}}$",
            "solution": "The problem statement is subjected to validation.\n\n**Step 1: Extract Givens**\n- **Study Context:** A South-South Cooperation (SSC) and triangular cooperation partnership involving a network of hospitals.\n- **Intervention:** A standardized infection-prevention bundle.\n- **Groups:**\n    - `$T$`: Treated hospitals that implement the intervention.\n    - `$C$`: Matched control hospitals that do not.\n- **Time Periods:**\n    - `$\\text{pre}$`: Period before implementation.\n    - `$\\text{post}$`: Period after implementation.\n- **Outcome:** Hospital-acquired infection (HAI) rate per $1{,}000$ patient-days.\n- **Notation:**\n    - `$\\bar{Y}_{g,t}$`: Sample mean HAI rate for group `$g \\in \\{T, C\\}$` at time `$t \\in \\{\\text{pre}, \\text{post}\\}$`.\n    - `$Y_{g,t}(1)$`: Potential outcome (HAI rate) for group `$g$` at time `$t$` if treated.\n    - `$Y_{g,t}(0)$`: Potential outcome (HAI rate) for group `$g$` at time `$t$` if untreated.\n- **Assumptions:**\n    1.  **Parallel Trends:** The trend in the outcome for the treated group, had it not been treated, would be the same as the trend in the control group. Formally, `$E[Y_{T, \\text{post}}(0) - Y_{T, \\text{pre}}(0)] = E[Y_{C, \\text{post}}(0) - Y_{C, \\text{pre}}(0)]$`.\n    2.  **Stable Unit Treatment Value Assumption (SUTVA):** The potential outcomes of one hospital are not affected by the treatment status of another hospital, and there is only one version of the treatment.\n    3.  **Composition Stability:** There are no systematic changes in the patient mix that differentially affect trends across the `$T$` versus `$C$` groups.\n- **Question:** Derive the sample estimator for the average effect of treatment on the treated hospitals (ATT) in the `$\\text{post}$` period, expressed as a function of the observed sample means.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Grounding:** The problem is firmly grounded in the well-established statistical methodology of Difference-in-Differences (DiD) estimation, a cornerstone of causal inference in econometrics and epidemiology. The context of global health and infection control is scientifically realistic.\n- **Well-Posed:** The problem is well-posed. It asks for the derivation of a specific quantity (the ATT estimator) under a clearly defined set of assumptions and notation. A unique, standard solution exists.\n- **Objective:** The problem is stated in precise, objective language common to statistics and public health research. It is free from ambiguity and subjectivity.\n\n**Step 3: Verdict and Action**\n- **Verdict:** The problem statement is valid. It is scientifically sound, well-posed, objective, and contains all necessary information for a rigorous derivation.\n- **Action:** Proceed with the derivation and solution.\n\n**Derivation from First Principles**\n\nThe parameter of interest is the Average Treatment effect on the Treated (ATT) in the `$\\text{post}$` period. This is the difference between the expected outcome for the treated group with treatment and the expected outcome for the treated group without treatment (the counterfactual).\n\nIn terms of population expectations, the ATT is defined as:\n$$ \\text{ATT} = E[Y_{T, \\text{post}}(1) - Y_{T, \\text{post}}(0)] $$\nThe term `$E[Y_{T, \\text{post}}(1)]$` is the expected outcome for the treated group in the post-period, given they received the treatment. This is observed. We denote its sample analogue as `$\\bar{Y}_{T,\\text{post}}$`.\n\nThe term `$E[Y_{T, \\text{post}}(0)]$` is the expected counterfactual outcome for the treated group in the post-period, i.e., what their HAI rate would have been had they *not* received the treatment. This quantity is not observed and must be estimated using the provided assumptions.\n\nThe core assumption for identifying the ATT is the parallel trends assumption. It states that the change in the untreated potential outcome from the `$\\text{pre}$` to the `$\\text{post}$` period would have been the same for both the treatment and control groups:\n$$ E[Y_{T, \\text{post}}(0) - Y_{T, \\text{pre}}(0)] = E[Y_{C, \\text{post}}(0) - Y_{C, \\text{pre}}(0)] $$\nWe can rearrange this equation to solve for the unobserved counterfactual, `$E[Y_{T, \\text{post}}(0)]$`:\n$$ E[Y_{T, \\text{post}}(0)] = E[Y_{T, \\text{pre}}(0)] + \\left( E[Y_{C, \\text{post}}(0)] - E[Y_{C, \\text{pre}}(0)] \\right) $$\nNow, we relate the potential outcomes to the observed outcomes:\n- In the `$\\text{pre}$` period, no group is treated, so `$Y_{T, \\text{pre}} = Y_{T, \\text{pre}}(0)$` and `$Y_{C, \\text{pre}} = Y_{C, \\text{pre}}(0)$`.\n- The control group is never treated, so `$Y_{C, \\text{post}} = Y_{C, \\text{post}}(0)$`.\n\nSubstituting these into the expression for the counterfactual:\n$$ E[Y_{T, \\text{post}}(0)] = E[Y_{T, \\text{pre}}] + \\left( E[Y_{C, \\text{post}}] - E[Y_{C, \\text{pre}}] \\right) $$\nThis provides an expression for the unobserved counterfactual based on observed population quantities.\n\nNow, we substitute this back into the definition of the ATT:\n$$ \\text{ATT} = E[Y_{T, \\text{post}}(1)] - E[Y_{T, \\text{post}}(0)] $$\nSince `$E[Y_{T, \\text{post}}(1)] = E[Y_{T, \\text{post}}]$` (the observed outcome for the treated group), we have:\n$$ \\text{ATT} = E[Y_{T, \\text{post}}] - \\left( E[Y_{T, \\text{pre}}] + E[Y_{C, \\text{post}}] - E[Y_{C, \\text{pre}}] \\right) $$\nRearranging the terms gives the well-known DiD formula:\n$$ \\text{ATT} = (E[Y_{T, \\text{post}}] - E[Y_{T, \\text{pre}}]) - (E[Y_{C, \\text{post}}] - E[Y_{C, \\text{pre}}]) $$\nThe problem asks for the sample estimator, `$\\widehat{\\text{ATT}}$`. This is found by replacing the population expectations (`$E[\\cdot]$`) with their sample analogues, the sample means (`$\\bar{Y}_{g,t}$`):\n$$ \\widehat{\\text{ATT}}_{\\text{DiD}} = (\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{T,\\text{pre}}) - (\\bar{Y}_{C,\\text{post}} - \\bar{Y}_{C,\\text{pre}}) $$\nThis estimator calculates the difference in the change over time for the treated group and the change over time for the control group. The change for the control group (`$\\bar{Y}_{C,\\text{post}} - \\bar{Y}_{C,\\text{pre}}$`) serves as the estimate for the counterfactual trend that the treated group would have experienced in the absence of the intervention.\n\n**Evaluation of Options**\n\n- **A. $(\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{T,\\text{pre}}) - (\\bar{Y}_{C,\\text{post}} - \\bar{Y}_{C,\\text{pre}})$**\n  This expression matches the derived sample estimator for the ATT `$\\widehat{\\text{ATT}}_{\\text{DiD}}$` perfectly. It represents the \"difference in differences\": the difference in the outcome change over time between the treatment group and the control group.\n  **Verdict: Correct.**\n\n- **B. $\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{C,\\text{post}}$**\n  This is a simple post-treatment comparison. It fails to account for any baseline differences between the treatment and control groups that existed prior to the intervention. If `$\\bar{Y}_{T, \\text{pre}} \\neq \\bar{Y}_{C, \\text{pre}}$`, this estimator is biased. The DiD method is specifically designed to correct for such pre-existing differences, assuming they are constant over time.\n  **Verdict: Incorrect.**\n\n- **C. $(\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{T,\\text{pre}}) + (\\bar{Y}_{C,\\text{post}} - \\bar{Y}_{C,\\text{pre}})$**\n  This expression adds the change over time in the treatment group to the change over time in the control group. This is not a meaningful estimator of a treatment effect. It combines the treatment effect with twice the secular trend, rather than isolating the treatment effect by differencing out the trend.\n  **Verdict: Incorrect.**\n\n- **D. $(\\bar{Y}_{C,\\text{post}} - \\bar{Y}_{C,\\text{pre}}) - (\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{T,\\text{pre}})$**\n  This is the negative of the correct DiD estimator. It calculates the change in the control group minus the change in the treatment group. This would estimate `-ATT`, not the ATT itself.\n  **Verdict: Incorrect.**\n\n- **E. $\\dfrac{\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{C,\\text{post}}}{\\bar{Y}_{C,\\text{pre}}} - \\dfrac{\\bar{Y}_{T,\\text{pre}} - \\bar{Y}_{C,\\text{pre}}}{\\bar{Y}_{C,\\text{pre}}}$**\n  This expression can be algebraically simplified:\n  $$ \\frac{(\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{C,\\text{post}}) - (\\bar{Y}_{T,\\text{pre}} - \\bar{Y}_{C,\\text{pre}})}{\\bar{Y}_{C,\\text{pre}}} = \\frac{(\\bar{Y}_{T,\\text{post}} - \\bar{Y}_{T,\\text{pre}}) - (\\bar{Y}_{C,\\text{post}} - \\bar{Y}_{C,\\text{pre}})}{\\bar{Y}_{C,\\text{pre}}} $$\n  This is the standard DiD estimator divided by the baseline mean of the control group, `$\\bar{Y}_{C,\\text{pre}}$`. While this can be a useful normalization to express the treatment effect in relative terms, it is not the ATT estimator itself, which is an absolute difference. The problem asks for the standard estimator derived from first principles, which is the additive form given in option A.\n  **Verdict: Incorrect.**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "In a world of finite budgets, proving an intervention is effective is not enough; we must also show it is an efficient use of scarce resources. This exercise puts you in the role of a health decision-maker tasked with choosing between a South-South Cooperation (SSC) platform and a more costly Triangular Cooperation (TC) model. Using the tools of Cost-Effectiveness Analysis, you will calculate and interpret Incremental Cost-Effectiveness Ratios ($ICER$s) to determine which strategy offers the most health gain for the money, while also navigating the real-world constraints of budgets and willingness-to-pay thresholds .",
            "id": "4997314",
            "problem": "A consortium of eight lower-middle-income countries is evaluating two cooperative delivery models to strengthen community health worker capacity:\n\n- A South-South Cooperation (SSC) platform (Intervention A) that pools training resources across partner countries.\n- A Triangular Cooperation (TC) variant (Intervention B) that adds technical assistance from a high-income partner to the SSC platform.\n\nAssume the comparator is the status quo with no additional cooperation. For a one-year implementation at scale across all eight countries, the estimated incremental costs and health effects (relative to the status quo) are:\n\n- Status quo: incremental cost $C_{0} = 0$ and incremental effect $E_{0} = 0$.\n- Intervention A (SSC only): incremental cost $C_{A} = 9.75 \\times 10^{6}$ and incremental effect $E_{A} = 29{,}800$ Disability-Adjusted Life Years (DALYs) averted.\n- Intervention B (SSC plus TC): incremental cost $C_{B} = 14.2 \\times 10^{6}$ and incremental effect $E_{B} = 36{,}000$ DALYs averted.\n\nA health authority uses a willingness-to-pay threshold of $\\lambda = 500$ United States dollars per DALY averted and has a hard annual budget constraint of $B = 12.0 \\times 10^{6}$ United States dollars for cooperation programs.\n\nBased on these data:\n1. Order the strategies by effectiveness and compute the sequential incremental cost-effectiveness ratios (ICERs) of moving from the less effective to the more effective strategy.\n2. Identify any strict or extended dominance among the strategies.\n3. Advise which strategy should be adopted given $\\lambda$ and the budget constraint $B$.\n\nRound any ICER you compute to four significant figures. Express any ICER in United States dollars per Disability-Adjusted Life Year (USD per DALY). For grading, report only the ICER (in USD per DALY) of the adopted strategy as your final numerical answer, rounded to four significant figures.",
            "solution": "This problem requires a cost-effectiveness analysis (CEA) to determine the optimal health intervention among three competing strategies, considering both a willingness-to-pay threshold and a budget constraint. The strategies are the Status Quo ($S_0$), Intervention A (South-South Cooperation), and Intervention B (Triangular Cooperation).\n\nThe incremental costs ($C$) and incremental health effects ($E$, in Disability-Adjusted Life Years or DALYs averted) relative to the status quo are given as:\n- Strategy $S_0$: $C_0 = 0$ USD, $E_0 = 0$ DALYs\n- Strategy A: $C_A = 9.75 \\times 10^{6}$ USD, $E_A = 29800$ DALYs\n- Strategy B: $C_B = 14.2 \\times 10^{6}$ USD, $E_B = 36000$ DALYs\n\nThe decision-making framework includes a willingness-to-pay threshold of $\\lambda = 500$ USD per DALY averted and a hard budget constraint of $B = 12.0 \\times 10^{6}$ USD.\n\nThe analysis proceeds in three steps as requested.\n\n**1. Ordering Strategies and Computing Sequential ICERs**\n\nFirst, we order the strategies by increasing effectiveness (health effect).\nThe effects are $E_0 = 0$, $E_A = 29800$, and $E_B = 36000$.\nThe order of increasing effectiveness is $S_0, A, B$.\n\nNext, we compute the sequential incremental cost-effectiveness ratio (ICER) for each step along this ordered path. The ICER is defined as the change in cost divided by the change in effect: $ICER = \\frac{\\Delta C}{\\Delta E}$.\n\nThe first comparison is between Strategy A and the Status Quo ($S_0$).\nThe incremental cost is $\\Delta C_{A,0} = C_A - C_0 = 9.75 \\times 10^{6} - 0 = 9.75 \\times 10^{6}$ USD.\nThe incremental effect is $\\Delta E_{A,0} = E_A - E_0 = 29800 - 0 = 29800$ DALYs.\nThe ICER for A relative to $S_0$ is:\n$$ICER_{A \\text{ vs } S_0} = \\frac{C_A - C_0}{E_A - E_0} = \\frac{9.75 \\times 10^{6}}{29800} \\approx 327.1812 \\text{ USD/DALY}$$\nRounding to four significant figures, $ICER_{A \\text{ vs } S_0} \\approx 327.2$ USD/DALY.\n\nThe second comparison is between Strategy B and Strategy A.\nThe incremental cost is $\\Delta C_{B,A} = C_B - C_A = 14.2 \\times 10^{6} - 9.75 \\times 10^{6} = 4.45 \\times 10^{6}$ USD.\nThe incremental effect is $\\Delta E_{B,A} = E_B - E_A = 36000 - 29800 = 6200$ DALYs.\nThe ICER for B relative to A is:\n$$ICER_{B \\text{ vs } A} = \\frac{C_B - C_A}{E_B - E_A} = \\frac{4.45 \\times 10^{6}}{6200} \\approx 717.7419 \\text{ USD/DALY}$$\nRounding to four significant figures, $ICER_{B \\text{ vs } A} \\approx 717.7$ USD/DALY.\n\n**2. Identifying Dominance**\n\nA strategy is subject to **strict dominance** if another available strategy is both more effective and less costly. Here, as we move from $S_0$ to A to B, both cost and effectiveness increase ($C_0 < C_A < C_B$ and $E_0 < E_A < E_B$). Therefore, no strategy is strictly dominated.\n\nA strategy is subject to **extended dominance** if it has an ICER greater than that of a more effective intervention. This occurs when the sequence of ICERs for strategies ordered by effectiveness is not monotonically increasing. We compare the sequential ICERs:\n$$ICER_{A \\text{ vs } S_0} \\approx 327.2 \\text{ USD/DALY}$$\n$$ICER_{B \\text{ vs } A} \\approx 717.7 \\text{ USD/DALY}$$\nSince $ICER_{A \\text{ vs } S_0} < ICER_{B \\text{ vs } A}$, the ICERs are increasing. This indicates that moving from A to B is incrementally more expensive per unit of health gain than moving from $S_0$ to A. There is no extended dominance. The efficiency frontier is formed by the path $S_0 \\to A \\to B$.\n\n**3. Advising on Strategy Adoption**\n\nThe final decision must satisfy both the budget constraint and the willingness-to-pay threshold.\n\nFirst, we apply the budget constraint $B = 12.0 \\times 10^{6}$ USD. We check the affordability of each strategy.\n- Strategy $S_0$: $C_0 = 0 \\le 12.0 \\times 10^{6}$ USD. (Affordable)\n- Strategy A: $C_A = 9.75 \\times 10^{6} \\le 12.0 \\times 10^{6}$ USD. (Affordable)\n- Strategy B: $C_B = 14.2 \\times 10^{6} > 12.0 \\times 10^{6}$ USD. (Unaffordable)\n\nStrategy B is immediately eliminated because its cost exceeds the available budget. The choice is now between Strategy A and the Status Quo ($S_0$).\n\nNext, we apply the willingness-to-pay threshold, $\\lambda = 500$ USD/DALY, to the remaining feasible options. To decide whether to adopt Strategy A over the Status Quo, we compare its ICER to $\\lambda$.\n$$ICER_{A \\text{ vs } S_0} \\approx 327.2 \\text{ USD/DALY}$$\nSince $327.2 < 500$, Strategy A is considered cost-effective relative to the Status Quo.\n\nGiven that Strategy A is affordable (its cost is within the budget) and cost-effective (its ICER is below the willingness-to-pay threshold), it is the preferred option over the Status Quo. It maximizes health gains within the given constraints.\n\nTherefore, the recommended strategy to be adopted is Strategy A.\n\nThe problem asks for the ICER of the adopted strategy. The adopted strategy is A, and its relevant ICER is the one calculated against the next best alternative on the efficiency frontier, which is the Status Quo ($S_0$).\nThe value is $ICER_{A \\text{ vs } S_0} = \\frac{9.75 \\times 10^{6}}{29800} \\approx 327.1812...$\nRounding this to four significant figures gives $327.2$.",
            "answer": "$$\\boxed{327.2}$$"
        }
    ]
}